Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207

NCT02390141 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoglycemia

Interventions

DRUG: ZP4207
DRUG: Placebo

Sponsor

Zealand Pharma